Diabetes Mellitus: Target Enzymes and Drugs highlights the importance of different targets in lead drug discovery and the importance of the synthesis of lead analogues. The book discusses the role of target enzymes, receptors, and related drugs in diabetes mellitus that are necessary for research on improving solutions for diabetes care. This unique resource provides information about all enzymes or receptors involved in diabetes pathophysiology to help describe target enzymes and potent antidiabetic drugs to improve patient care.This type of research is needed for the understanding of the effects of drugs in order to improve future treatments and care of patients with diabetes.
- Describes Pathophysiology and the Types of Diabetes
- Discusses Insulin and Insulin Mechanisms in Diabetes Mellitus
- Offers information on Antidiabetic drugs from Natural Sources
- Includes the FDA approved antidiabetic drugs and their adverse effects
Sprache
Verlagsort
Dateigröße
ISBN-13
978-0-443-29130-2 (9780443291302)
Schweitzer Klassifikation
1. Introduction to Diabetes Mellitus2. Dipeptidyl Peptidase-4 (DPP-4) Enzyme in Diabetes Mellitus3. PPAR-¿ (Peroxisome proliferator-activated receptor) receptor in Diabetes Mellitus4. a-glucosidase in Diabetes Mellitus5. Sodium-glucose cotransporter-2 (SGLT2) in Diabetes Mellitus6. Insulin in Diabetes Mellitus7. Glucagon-like peptide-1 receptor in Diabetes Mellitus8. Amylin in Diabetes Mellitus9. Miscellaneous drug combinations in Diabetes Mellitus10. Antidiabetic drugs from Natural Sources11. Future challenges in targeted drug for Diabetes Mellitus
